Evidence map›Paper›PMID 38787239›Full record

ArticlePathogens (Basel, Switzerland)2024

Rapid Dissemination of

Zhenbao Ma, Bo Wang, Dongping Zeng, Huanzhong Ding, Zhenling Zeng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Genomic characterization and global lineage-plasmid context of aOne health (Amsterdam, Netherlands) · 2026
    Article
  3. Cross-species transmission ofFrontiers in cellular and infection microbiology · 2026
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhenbao MaGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou 510642, China.ORCID 0000-0002-0588-1455
Bo WangGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou 510642, China.
Dongping ZengGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou 510642, China.ORCID 0000-0002-2006-5755
Huanzhong DingGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou 510642, China.
Zhenling ZengGuangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou 510642, China.

Funding

National Natural Science Foundation of China 32121004
6 · The paper itself

Abstract

Although carbapenems have not been approved for animal use, carbapenem-resistant

Indexed as

beta-LactamasesChickensEscherichia coliEscherichia coli InfectionsFarmsPlasmidsPoultry DiseasesRepliconAnimalsAnti-Bacterial AgentsCarbapenem-Resistant EnterobacteriaceaeCarbapenemsChinaFecesMicrobial Sensitivity TestsWhole Genome SequencingAnti-Bacterial Agentsbeta lactamase NDM-5, E colibeta-LactamasesCarbapenemsCRECgenetic featureshorizontal transferwhole-genome sequencing

Identifiers

PMID38787239
PMCPMC11124502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.